Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Cboe UK CHF

IVF Hartmann Holding AG (VBSNZ.XC)

Compare
155.00
-3.00
(-1.90%)
At close: April 4 at 2:40:07 PM GMT+1
Loading Chart for VBSNZ.XC
  • Previous Close 158.00
  • Open 156.00
  • Bid --
  • Ask --
  • Day's Range 155.00 - 159.00
  • 52 Week Range 126.00 - 159.00
  • Volume 55
  • Avg. Volume 10
  • Market Cap (intraday) 379.2M
  • Beta (5Y Monthly) 0.37
  • PE Ratio (TTM) 18.32
  • EPS (TTM) 8.46
  • Earnings Date --
  • Forward Dividend & Yield 3.20 (2.06%)
  • Ex-Dividend Date Apr 17, 2025
  • 1y Target Est --

IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. It offers medical products, accident prevention and hygiene products, disinfection and cleaning equipment, body care, personal hygiene, household, tools, packaging, and clothing and textile products. The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993. The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland. IVF Hartmann Holding AG is a subsidiary of Paul Hartmann Finance B.V.

www.ivf.hartmann.info

270

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VBSNZ.XC

View More

Performance Overview: VBSNZ.XC

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

VBSNZ.XC
3.33%
MSCI WORLD (^990100-USD-STRD)
10.56%

1-Year Return

VBSNZ.XC
15.70%
MSCI WORLD (^990100-USD-STRD)
2.44%

3-Year Return

VBSNZ.XC
7.62%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

VBSNZ.XC
5.80%
MSCI WORLD (^990100-USD-STRD)
87.20%

Compare To: VBSNZ.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VBSNZ.XC

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    364.80M

  • Enterprise Value

    257.18M

  • Trailing P/E

    18.32

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.34

  • Price/Book (mrq)

    2.45

  • Enterprise Value/Revenue

    1.62

  • Enterprise Value/EBITDA

    8.70

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.77%

  • Return on Assets (ttm)

    7.61%

  • Return on Equity (ttm)

    13.38%

  • Revenue (ttm)

    159.03M

  • Net Income Avi to Common (ttm)

    20.3M

  • Diluted EPS (ttm)

    8.46

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    108.93M

  • Total Debt/Equity (mrq)

    0.50%

  • Levered Free Cash Flow (ttm)

    34.62M

Research Analysis: VBSNZ.XC

View More

Company Insights: VBSNZ.XC

Research Reports: VBSNZ.XC

View More

People Also Watch